Exosomes and exosome-mimetics as targeted drug carriers: Where we stand and what the future holds?

A decade of metaproteomics: Where we stand and what the future holds

We are living through exciting times during which we are able to unravel the "microbial dark matter" in and around us through the application of high-resolution "meta-omics". Metaproteomics offers the ability to resolve the major catalytic units of microbial populations and thereby allows the establishment of genotype-phenotype linkages from in situ samples. A decade has passed since the term "...

where do we stand and what comes next?

The Hippocampus and Imagining the Future: Where Do We Stand?

Recent neuroimaging work has demonstrated that the hippocampus is engaged when imagining the future, in some cases more than when remembering the past. It is possible that this hippocampal activation reflects recombining details into coherent scenarios and/or the encoding of these scenarios into memory for later use. However, inconsistent findings have emerged from recent studies of future simu...

The Battle Against COVID-19: Where Do We Stand Now?

Endovascular therapy in acute ischemic stroke: where we are, the challenges we face and what the future holds.

Stroke is the third leading cause of death and a leading cause of severe long-term disability worldwide. It costs the world's economy billions of dollars each year in physician services, hospital costs, lost wages and decreased productivity. Rapid advances in medical technology have resulted in an explosion of treatment strategies in the management of acute ischemic stroke. Each clinical scenar...